ipo
Stage
2014
Founded
4
Investors
About
Zentalis Pharmaceuticals is a clinical-stage company advancing azenosertib, a first-in-class WEE1 inhibitor, for ovarian cancer and other tumor types.
Explore Zentalis's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.